Improvement in Impaired Social Cognition but Not Seizures by Everolimus in a Child with Tuberous Sclerosis-Associated Autism through Increased Serum Antioxidant Proteins and Oxidant/Antioxidant Status

We investigated the effect of the mammalian target of rapamycin (mTOR) inhibitor everolimus on tuberous sclerosis complex- (TSC-) associated autistic symptoms and focal seizures with impaired awareness in a female child with TSC. We further evaluated the relationship between improved autistic sympto...

Full description

Saved in:
Bibliographic Details
Main Authors: Kunio Yui, George Imataka, Hitomi Sasaki, Yohei Kawasaki, Tohru Okanshi, Ryoichi Shiroki, Shigemi Yoshihara
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Case Reports in Pediatrics
Online Access:http://dx.doi.org/10.1155/2019/2070619
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564639820414976
author Kunio Yui
George Imataka
Hitomi Sasaki
Yohei Kawasaki
Tohru Okanshi
Ryoichi Shiroki
Shigemi Yoshihara
author_facet Kunio Yui
George Imataka
Hitomi Sasaki
Yohei Kawasaki
Tohru Okanshi
Ryoichi Shiroki
Shigemi Yoshihara
author_sort Kunio Yui
collection DOAJ
description We investigated the effect of the mammalian target of rapamycin (mTOR) inhibitor everolimus on tuberous sclerosis complex- (TSC-) associated autistic symptoms and focal seizures with impaired awareness in a female child with TSC. We further evaluated the relationship between improved autistic symptoms and seizures and increased the serum levels of the antioxidant proteins, ceruloplasmin (Cp) and transferrin (Tf), and oxidant-antioxidant status indicated by the oxidant marker oxidized low-density lipoprotein (ox-LDL) and the antioxidant marker total antioxidant power (TAP). Everolimus treatment improved impaired social cognition and autistic behaviors; however, seizure and epileptic activity persisted. Serum Cp and Tf levels gradually increased in response to improved autistic symptoms. Serum TAP levels gradually decreased from baseline to the lowest value at 16 weeks and then increased at 24 weeks, showing a trend toward decreased total score of the Aberrant Behavior Checklist. This study revealed that everolimus treatment improved impaired social cognition with increased serum levels of the copper mediator (Cp) and iron mediator (Tf) via homeostatic control of mTOR activity accompanied by overlap of the oxidant-antioxidant system. Everolimus had no effect on TSC-related epileptiform discharges, and thus, the autistic symptoms and epileptic activity may be two independent end results of a common central nervous system disorder including mTOR hyperactivity. This trial is registered with JMAS-IIA00258.
format Article
id doaj-art-d92799c0268944029d7531fff11ca386
institution Kabale University
issn 2090-6803
2090-6811
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Case Reports in Pediatrics
spelling doaj-art-d92799c0268944029d7531fff11ca3862025-02-03T01:10:40ZengWileyCase Reports in Pediatrics2090-68032090-68112019-01-01201910.1155/2019/20706192070619Improvement in Impaired Social Cognition but Not Seizures by Everolimus in a Child with Tuberous Sclerosis-Associated Autism through Increased Serum Antioxidant Proteins and Oxidant/Antioxidant StatusKunio Yui0George Imataka1Hitomi Sasaki2Yohei Kawasaki3Tohru Okanshi4Ryoichi Shiroki5Shigemi Yoshihara6Department of Urology, Fujita Health University School of Medicine, Aichi 470-1192, JapanDepartment of Pediatrics, Dokkyo Medical University, Mibu, Tochigi 321-0293, JapanDepartment of Urology, Fujita Health University School of Medicine, Aichi 470-1192, JapanClinical Research Center, Chiba University Hospital, Chiba 260-8677, JapanDepartment of Child Neurology, Seirei Hamamatsu General Hospital, Hamamatsu 430-8558, JapanDepartment of Urology, Fujita Health University School of Medicine, Aichi 470-1192, JapanDepartment of Pediatrics, Dokkyo Medical University, Mibu, Tochigi 321-0293, JapanWe investigated the effect of the mammalian target of rapamycin (mTOR) inhibitor everolimus on tuberous sclerosis complex- (TSC-) associated autistic symptoms and focal seizures with impaired awareness in a female child with TSC. We further evaluated the relationship between improved autistic symptoms and seizures and increased the serum levels of the antioxidant proteins, ceruloplasmin (Cp) and transferrin (Tf), and oxidant-antioxidant status indicated by the oxidant marker oxidized low-density lipoprotein (ox-LDL) and the antioxidant marker total antioxidant power (TAP). Everolimus treatment improved impaired social cognition and autistic behaviors; however, seizure and epileptic activity persisted. Serum Cp and Tf levels gradually increased in response to improved autistic symptoms. Serum TAP levels gradually decreased from baseline to the lowest value at 16 weeks and then increased at 24 weeks, showing a trend toward decreased total score of the Aberrant Behavior Checklist. This study revealed that everolimus treatment improved impaired social cognition with increased serum levels of the copper mediator (Cp) and iron mediator (Tf) via homeostatic control of mTOR activity accompanied by overlap of the oxidant-antioxidant system. Everolimus had no effect on TSC-related epileptiform discharges, and thus, the autistic symptoms and epileptic activity may be two independent end results of a common central nervous system disorder including mTOR hyperactivity. This trial is registered with JMAS-IIA00258.http://dx.doi.org/10.1155/2019/2070619
spellingShingle Kunio Yui
George Imataka
Hitomi Sasaki
Yohei Kawasaki
Tohru Okanshi
Ryoichi Shiroki
Shigemi Yoshihara
Improvement in Impaired Social Cognition but Not Seizures by Everolimus in a Child with Tuberous Sclerosis-Associated Autism through Increased Serum Antioxidant Proteins and Oxidant/Antioxidant Status
Case Reports in Pediatrics
title Improvement in Impaired Social Cognition but Not Seizures by Everolimus in a Child with Tuberous Sclerosis-Associated Autism through Increased Serum Antioxidant Proteins and Oxidant/Antioxidant Status
title_full Improvement in Impaired Social Cognition but Not Seizures by Everolimus in a Child with Tuberous Sclerosis-Associated Autism through Increased Serum Antioxidant Proteins and Oxidant/Antioxidant Status
title_fullStr Improvement in Impaired Social Cognition but Not Seizures by Everolimus in a Child with Tuberous Sclerosis-Associated Autism through Increased Serum Antioxidant Proteins and Oxidant/Antioxidant Status
title_full_unstemmed Improvement in Impaired Social Cognition but Not Seizures by Everolimus in a Child with Tuberous Sclerosis-Associated Autism through Increased Serum Antioxidant Proteins and Oxidant/Antioxidant Status
title_short Improvement in Impaired Social Cognition but Not Seizures by Everolimus in a Child with Tuberous Sclerosis-Associated Autism through Increased Serum Antioxidant Proteins and Oxidant/Antioxidant Status
title_sort improvement in impaired social cognition but not seizures by everolimus in a child with tuberous sclerosis associated autism through increased serum antioxidant proteins and oxidant antioxidant status
url http://dx.doi.org/10.1155/2019/2070619
work_keys_str_mv AT kunioyui improvementinimpairedsocialcognitionbutnotseizuresbyeverolimusinachildwithtuberoussclerosisassociatedautismthroughincreasedserumantioxidantproteinsandoxidantantioxidantstatus
AT georgeimataka improvementinimpairedsocialcognitionbutnotseizuresbyeverolimusinachildwithtuberoussclerosisassociatedautismthroughincreasedserumantioxidantproteinsandoxidantantioxidantstatus
AT hitomisasaki improvementinimpairedsocialcognitionbutnotseizuresbyeverolimusinachildwithtuberoussclerosisassociatedautismthroughincreasedserumantioxidantproteinsandoxidantantioxidantstatus
AT yoheikawasaki improvementinimpairedsocialcognitionbutnotseizuresbyeverolimusinachildwithtuberoussclerosisassociatedautismthroughincreasedserumantioxidantproteinsandoxidantantioxidantstatus
AT tohruokanshi improvementinimpairedsocialcognitionbutnotseizuresbyeverolimusinachildwithtuberoussclerosisassociatedautismthroughincreasedserumantioxidantproteinsandoxidantantioxidantstatus
AT ryoichishiroki improvementinimpairedsocialcognitionbutnotseizuresbyeverolimusinachildwithtuberoussclerosisassociatedautismthroughincreasedserumantioxidantproteinsandoxidantantioxidantstatus
AT shigemiyoshihara improvementinimpairedsocialcognitionbutnotseizuresbyeverolimusinachildwithtuberoussclerosisassociatedautismthroughincreasedserumantioxidantproteinsandoxidantantioxidantstatus